Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices
dc.contributor.author | Pérez-Ayuso, Rosa María | |
dc.contributor.author | Valderrama, Sebastián | |
dc.contributor.author | Espinoza, Manuel | |
dc.contributor.author | Rollán, Antonio | |
dc.contributor.author | Sánchez, René | |
dc.contributor.author | Otarola, Francisco | |
dc.contributor.author | Medina, Brenda | |
dc.contributor.author | Riquelme, Arnoldo | |
dc.date.accessioned | 2021-10-15T14:31:17Z | |
dc.date.available | 2021-10-15T14:31:17Z | |
dc.date.issued | 2010 | |
dc.description.abstract | Background. Gastroesophageal variceal bleeding is a common complication of portal hypertension. Currentguidelines recommend β-blockers for primary prophylaxis. However, evidence suggests that endoscopic va-riceal ligation (EVL) reduce bleeding episodes. Aims. To compare endoscopic EVL with propranolol (PPL)for primary prophylaxis of variceal bleeding. Methods. We conducted a randomized controlled trial. Over a9-year period, 75 patients with cirrhosis and high-risk esophageal varices (HREV) were recruited and alloca-ted to EVL (n=39) or PPL (n=36). Primary outcome was variceal bleeding. Secondary outcomes were survi-val, source of bleeding and serious adverse events. Analyses were made by intention-to-treat. Results.Baseline characteristics were similar. Medium follow-up was 1647±1096 days. Complete follow-up wasachieved in 85% of patients. Variceal bleeding occurred in 12% of EVL and in 25% of PPL group (p=0.17).The actuarial risks of bleeding after 2 years were similar in both groups. Overall mortality was 51% in EVLand 33% in PPL group (p=0.17). Patients in the EVL group showed a lower rate of esophageal variceal blee-ding (5.1% v/s 25%, p=0.027) and a higher rate of subcardial variceal bleeding compared with PPL group(7.7% v/s 0%, p=0.027). Serious adverse events related to EVL occurred in 2 patients, including 1 death.Conclusions. The present study supports that PPL should be considered the first choice in primary pro-phylaxis of variceal bleeding offering similar effects and lower severe adverse events compared with EVL | es |
dc.identifier.citation | Annals of Hepatology January-March, Vol. 9 No.1, 2010: 15-22 | es |
dc.identifier.uri | http://hdl.handle.net/11447/4842 | |
dc.language.iso | en_US | es |
dc.subject | Primary prophylaxis | es |
dc.subject | Endoscopic band ligation | es |
dc.subject | Propranolol | es |
dc.subject | Beta-Blockers | es |
dc.subject | Variceal bleeding | es |
dc.subject | Cirrhosis | es |
dc.title | Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices | es |
dc.type | Article | es |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices.pdf
- Size:
- 440.32 KB
- Format:
- Adobe Portable Document Format
- Description:
- Texto Completo
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: